Capricor Therapeutics, Inc. (CAPR)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.02
+0.07
(+0.78%)
After-Hours: 20:00
Capricor Therapeutics Total Liabilities (Quarterly) : 122.52M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.52M |
| March 31, 2026 | 47.58M |
| December 31, 2025 | 54.15M |
| September 30, 2025 | 42.57M |
| June 30, 2025 | 28.59M |
| March 31, 2025 | 26.12M |
| December 31, 2024 | 26.81M |
| September 30, 2024 | 24.69M |
| June 30, 2024 | 26.78M |
| March 31, 2024 | 31.01M |
| December 31, 2023 | 36.13M |
| September 30, 2023 | 38.94M |
| June 30, 2023 | 43.28M |
| March 31, 2023 | 47.66M |
| December 31, 2022 | 38.31M |
| September 30, 2022 | 38.50M |
| June 30, 2022 | 39.34M |
| March 31, 2022 | 40.28M |
| December 31, 2021 | 9.962M |
| September 30, 2021 | 6.365M |
| June 30, 2021 | 6.550M |
| March 31, 2021 | 7.164M |
| December 31, 2020 | 6.419M |
| September 30, 2020 | 5.779M |
| June 30, 2020 | 5.472M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.701M |
| December 31, 2019 | 4.274M |
| September 30, 2019 | 4.337M |
| June 30, 2019 | 4.943M |
| March 31, 2019 | 4.877M |
| December 31, 2018 | 4.632M |
| September 30, 2018 | 5.252M |
| June 30, 2018 | 4.696M |
| March 31, 2018 | 4.854M |
| December 31, 2017 | 5.047M |
| September 30, 2017 | 20.06M |
| June 30, 2017 | 20.80M |
| March 31, 2017 | 21.26M |
| December 31, 2016 | 22.75M |
| September 30, 2016 | 24.42M |
| June 30, 2016 | 19.01M |
| March 31, 2016 | 18.07M |
| December 31, 2015 | 17.10M |
| September 30, 2015 | 17.96M |
| June 30, 2015 | 19.14M |
| March 31, 2015 | 20.15M |
| December 31, 2014 | 19.88M |
| September 30, 2014 | 20.75M |
| June 30, 2014 | 21.52M |
| March 31, 2014 | 17.64M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 236.98M |
| SELLAS Life Sciences Group, Inc. | 7.726M |
| Sionna Therapeutics, Inc. | 17.47M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Cytokinetics, Inc. | 2.098B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.74M |
| Shareholders Equity (Quarterly) | 246.22M |
| Debt to Equity Ratio | 0.3698 |
| Current Ratio | 7.346 |
| Net Debt Paydown Yield | -1.24% |